Published in Allergy on August 01, 2007
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. World Allergy Organ J (2010) 2.01
Clinical practice. Diagnosis and treatment of cow's milk allergy. Eur J Pediatr (2009) 1.11
Oral peanut challenge identifies an allergy but the peanut allergen threshold sensitivity is not reproducible. PLoS One (2013) 0.99
Failure of introduction of food allergens after negative oral food challenge tests in children. Eur J Pediatr (2015) 0.80
Predictive value of specific IgE for clinical peanut allergy in children: relationship with eczema, asthma, and setting (primary or secondary care). Clin Transl Allergy (2013) 0.76
A new framework for the documentation and interpretation of oral food challenges in population-based and clinical research. Allergy (2016) 0.75
Standardization of double blind placebo controlled food challenge with soy within a multicentre trial. Clin Transl Allergy (2016) 0.75
Late type of bronchial response to milk ingestion challenge: a comparison of open and double-blind challenge. J Allergy (Cairo) (2011) 0.75
Diagnostic evaluation of food-related allergic diseases. Allergy Asthma Clin Immunol (2009) 0.75
Mono-sensitisation to peanut component Ara h 6: a case series of five children and literature review. Eur J Pediatr (2016) 0.75
Towards better triage of infants suspected of cow's milk allergy: development of a preliminary multivariable diagnostic index. Eur J Pediatr (2012) 0.75
Primary prevention of food allergy in children and adults: systematic review. Allergy (2014) 2.75
The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy (2013) 2.02
[When the treatment in children with asthma fails: first other reasons should be sought before prescribing more medication]. Ned Tijdschr Geneeskd (2005) 2.01
Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis (1992) 1.89
EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy (2014) 1.80
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy (2014) 1.73
Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. Am J Respir Crit Care Med (1998) 1.72
Intestinal handling-induced mast cell activation and inflammation in human postoperative ileus. Gut (2007) 1.63
The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children. Dutch CNSLD Study Group. Eur Respir J (1993) 1.52
Parents report better health-related quality of life for their food-allergic children than children themselves. Clin Exp Allergy (2011) 1.51
Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions. Allergy (2012) 1.48
Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings. Clin Exp Allergy (2009) 1.44
Infant feeding and allergy prevention: a review of current knowledge and recommendations. A EuroPrevall state of the art paper. Allergy (2009) 1.44
[Asthma in children; consensus by pediatric pulmonologists on long-term treatment. I. Diagnosis]. Ned Tijdschr Geneeskd (1991) 1.41
Occurrence of a late response to exercise in asthmatic children: multiple regression approach using time-matched baseline and histamine control days. Eur Respir J (1996) 1.40
[Anaphylaxis in two children caused by peanut and nut allergies; recommendations for treatment]. Ned Tijdschr Geneeskd (2007) 1.38
[Coughing and wheezing children: improvement after parents stop smoking]. Ned Tijdschr Geneeskd (1998) 1.38
Mite-specific IgE cannot be used as a surrogate for mite exposure. Allergy (1995) 1.38
[Two children with severe recurrent infections and the X-linked hyper-IgM syndrome]. Ned Tijdschr Geneeskd (2003) 1.38
Inhaled corticosteroids and growth of airway function in asthmatic children. Eur Respir J (2004) 1.36
The epidemiology of anaphylaxis in Europe: a systematic review. Allergy (2013) 1.26
Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. Am Rev Respir Dis (1993) 1.24
Comparison of antibody measurements against Aspergillus fumigatus by means of double-diffusion and enzyme-linked immunosorbent assay (ELISA). J Allergy Clin Immunol (1983) 1.24
Development and validation of a self-administered Food Allergy Quality of Life Questionnaire for children. Clin Exp Allergy (2008) 1.23
Health-related quality of life of food allergic patients: comparison with the general population and other diseases. Allergy (2009) 1.21
No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy (2006) 1.12
Role and interpretation of total serum IgE measurements in the diagnosis of allergic airway disease in adults. Allergy (2003) 1.10
Respiratory health in prematurely born preschool children with and without bronchopulmonary dysplasia. J Pediatr (2007) 1.09
House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: a possible delay in the manifestation of clinical asthma? J Allergy Clin Immunol (1997) 1.09
Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis (1988) 1.05
Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy (2001) 1.05
Food allergy QoL questionnaire for children aged 0-12 years: content, construct, and cross-cultural validity. Clin Exp Allergy (2008) 1.02
Lung function and bronchial responsiveness in children who had infantile bronchiolitis. Pediatr Pulmonol (1987) 1.01
Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity. Eur Respir J (1999) 1.01
Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol (2000) 1.00
One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height. Am J Respir Crit Care Med (2001) 1.00
Forced oscillation technique. Reference values for resistance and reactance over a frequency spectrum of 2-26 Hz in healthy children aged 2.3-12.5 years. Bull Eur Physiopathol Respir (1985) 1.00
Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J (2004) 1.00
Management of anaphylaxis: a systematic review. Allergy (2013) 0.99
Bronchial responsiveness in children. Pediatr Clin North Am (1983) 0.98
Assessment of bronchodilator response in children with asthma. Dutch CNSLD Study Group. Eur Respir J (1993) 0.98
Comorbidities of asthma during childhood: possibly important, yet poorly studied. Eur Respir J (2010) 0.98
Comparison of forced oscillometry and forced expirations for measuring dose-related responses to inhaled methacholine in asthmatic children. Bull Eur Physiopathol Respir (1987) 0.97
Systematic review on cashew nut allergy. Allergy (2014) 0.96
Sensitization to lupine flour: is it clinically relevant? Clin Exp Allergy (2010) 0.95
Health-related quality of life of food allergic patients measured with generic and disease-specific questionnaires. Allergy (2010) 0.95
Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics (1993) 0.94
Longitudinal validity and responsiveness of the Food Allergy Quality of Life Questionnaire - Parent Form in children 0-12 years following positive and negative food challenges. Clin Exp Allergy (2010) 0.93
The effects of food allergy on quality of life. Chem Immunol Allergy (2015) 0.93
Quality of life measures for food allergy. Clin Exp Allergy (2012) 0.92
Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up. J Inherit Metab Dis (2005) 0.92
EAACI Food Allergy and Anaphylaxis Guidelines. Food allergy health-related quality of life measures. Allergy (2014) 0.91
Ready-to-use introduction schedules for first exposure to allergenic foods in children at home. Allergy (2008) 0.91
Influence of respiratory exacerbations on lung function variables and nutritional status in CF patients. Acta Paediatr Scand Suppl (1985) 0.90
Peak flow variation in childhood asthma: relationship to symptoms, atopy, airways obstruction and hyperresponsiveness. Dutch CNSLD Study Group. Eur Respir J (1997) 0.90
Disease-specific health-related quality of life instruments for IgE-mediated food allergy. Allergy (2014) 0.90
Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group. Eur Respir J (1994) 0.89
Cultivation of fungi in synthetic and semi-synthetic liquid medium. II. Immunochemical properties of the antigenic and allergenic extracts. Allergy (1985) 0.89
Plasma histamine concentrations and complement activation during house dust mite-provoked bronchial obstructive reactions. Clin Allergy (1983) 0.89
Prognostic characteristics of asthma diagnosis in early childhood in clinical practice. Acta Paediatr (1999) 0.88
Validation of novel recipes for double-blind, placebo-controlled food challenges in children and adults. Allergy (2011) 0.87
Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer? Mol Genet Metab (2006) 0.87
Nebulised budesonide in severe childhood asthma. Lancet (1989) 0.87
Acute and long-term management of food allergy: systematic review. Allergy (2013) 0.86
The allergenic and antigenic properties of spore extracts of Aspergillus fumigatus: a comparative study of spore extracts with mycelium and culture filtrate extracts. J Allergy Clin Immunol (1984) 0.86
Development, validity and reliability of the food allergy independent measure (FAIM). Allergy (2009) 0.86
Risk factors for exacerbations and hospital admissions in asthma of early childhood. Pediatr Pulmonol (2000) 0.86
Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis. Lancet (1993) 0.86
Bronchial responsiveness in asthmatic children aged 3 to 8 years measured by forced pseudo-random noise oscillometry. Bull Eur Physiopathol Respir (1986) 0.85
Mastocytosis and adverse reactions to biogenic amines and histamine-releasing foods: what is the evidence? Neth J Med (2005) 0.84
Development and validation of the Food Allergy Quality of Life Questionnaire - Adult Form. Allergy (2009) 0.84
Class-specific antibody determination against Aspergillus fumigatus by means of the enzyme-linked immunosorbent assay. III. Comparative study: IgG, IgA, IgM ELISA titers, precipitating antibodies and IgE binding after fractionation of the antigen. Int Arch Allergy Appl Immunol (1986) 0.84
Sibling effect on atopy in children of patients with asthma. Clin Exp Allergy (2003) 0.82
Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J Allergy Clin Immunol (1994) 0.82
Identification of low allergenic apple cultivars using skin prick tests and oral food challenges. Allergy (2010) 0.82
Standardization of allergenic extracts of Aspergillus fumigatus. Liberation of IgE-binding components during cultivation. Int Arch Allergy Appl Immunol (1985) 0.82
Hospital admissions and readmissions for asthma in the age group 0-4 years. Pediatr Pulmonol (2001) 0.82
Rapidly progressive adenomatous polyposis in a patient with germline mutations in both the APC and MLH1 genes: the worst of two worlds. Gut (2003) 0.82
Dietary assessment in children adhering to a food allergen avoidance diet for allergy prevention. Eur J Clin Nutr (2006) 0.81
Adolescent-parent disagreement on health-related quality of life of food-allergic adolescents: who makes the difference? Allergy (2011) 0.81
Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC). Liver (2002) 0.81